<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>药时代 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-11-30T11:31:49+08:00</updated>
  <subtitle>欢迎您走进药时代！这是一个千载难逢的医药研发新时代！我们分享最新的有价值的行业资讯，讲述医药背后感人的故事，举办形式多样、内容丰富的线上线下活动，与朋友们一起学习成长，将新药研发事业进行到底，让新药带给世界更多更大的健康</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>新技术浪潮下，人源化动物模型能否化冲击为动力，为新药研发再次赋能？</title>
    <updated>2020-11-30T08:00:19+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-30:/s/zKcSS1ntN3ok5xnUS4QyPw</id>
    <link href="https://mp.weixin.qq.com/s/zKcSS1ntN3ok5xnUS4QyPw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>中美冠科生物医药研讨会：新技术、新平台引领肿瘤药物研发新突破—北京站</title>
    <updated>2020-11-30T08:00:19+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-30:/s/oQd3NlJqT9TAPFPPoBJ-wg</id>
    <link href="https://mp.weixin.qq.com/s/oQd3NlJqT9TAPFPPoBJ-wg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>德琪医药梅建明博士荣膺“2020中国经济新闻人物·新经济领军人物”</title>
    <updated>2020-11-30T08:00:19+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-30:/s/EUYnBHIaUY6pmcckCe_v8A</id>
    <link href="https://mp.weixin.qq.com/s/EUYnBHIaUY6pmcckCe_v8A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>CAR-T疗法实体瘤耐受良好！这种最常见儿童脑瘤，迎来CAR-T疗法新进展</title>
    <updated>2020-11-30T08:00:19+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-30:/s/P_IyDhQhPae5WIt_GagGzA</id>
    <link href="https://mp.weixin.qq.com/s/P_IyDhQhPae5WIt_GagGzA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>无心插柳——致重磅药普瑞巴林的发现</title>
    <updated>2020-11-30T08:00:19+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-30:/s/2f9_p7oaKNJpAx3WFejLYQ</id>
    <link href="https://mp.weixin.qq.com/s/2f9_p7oaKNJpAx3WFejLYQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>推荐！钱塘新区杭州医药港招商宣传片</title>
    <updated>2020-11-30T08:00:19+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-30:/s/o_1FANK18qBNY2ApsLiqTA</id>
    <link href="https://mp.weixin.qq.com/s/o_1FANK18qBNY2ApsLiqTA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>豪森药业创新药项目荣获第六届中国工业大奖表彰奖</title>
    <updated>2020-11-29T09:00:47+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-29:/s/jB0ZAv2nj6EKZm-GRpfCkw</id>
    <link href="https://mp.weixin.qq.com/s/jB0ZAv2nj6EKZm-GRpfCkw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>浅谈：药物晶型与晶型药物</title>
    <updated>2020-11-29T09:00:47+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-29:/s/gN5GujT-TICfTqULHM8YeQ</id>
    <link href="https://mp.weixin.qq.com/s/gN5GujT-TICfTqULHM8YeQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>Vibegron错过2a期试验主要终点，似无缘IBS适应症</title>
    <updated>2020-11-29T09:00:47+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-29:/s/3DcyKq9lUzbNHSr96g71AQ</id>
    <link href="https://mp.weixin.qq.com/s/3DcyKq9lUzbNHSr96g71AQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>药明直播间|生物制药系列(六)：针对抗体偶联药物的分析能力及策略</title>
    <updated>2020-11-29T09:00:47+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-29:/s/HbTC0G3DnhxswUAlHRuZeg</id>
    <link href="https://mp.weixin.qq.com/s/HbTC0G3DnhxswUAlHRuZeg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>精彩的小视频 祝同药们周末愉快！~~</title>
    <updated>2020-11-29T09:00:47+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-29:/s/BLfiX0m_QlgjlbzitidsBA</id>
    <link href="https://mp.weixin.qq.com/s/BLfiX0m_QlgjlbzitidsBA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>刘阳教授 | 我的免疫学情缘</title>
    <updated>2020-11-28T08:03:57+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-28:/s/Mcg_RNLGWmDJBcuz5BEgmw</id>
    <link href="https://mp.weixin.qq.com/s/Mcg_RNLGWmDJBcuz5BEgmw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>辉煌不再，屡遭临床挫折的Galapagos出售旗下CRO公司</title>
    <updated>2020-11-28T08:03:57+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-28:/s/acwvvWpgpPLMqGKxBX_y4Q</id>
    <link href="https://mp.weixin.qq.com/s/acwvvWpgpPLMqGKxBX_y4Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>独家｜基因治疗载体AAV“安全神话破灭”？6位专家全方位解读：太炒作了，别因噎废食</title>
    <updated>2020-11-28T08:03:57+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-28:/s/jzdhyW3pr9AnF9PInJN2KA</id>
    <link href="https://mp.weixin.qq.com/s/jzdhyW3pr9AnF9PInJN2KA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>JVI前主编：我是如何走到今天的</title>
    <updated>2020-11-28T08:03:57+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-28:/s/5SNqHX9aU8ZWSKOsTU-c-Q</id>
    <link href="https://mp.weixin.qq.com/s/5SNqHX9aU8ZWSKOsTU-c-Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>博腾药时代直播间 | 新药开发过程中的CMC一体化项目管理的分享</title>
    <updated>2020-11-28T08:03:57+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-28:/s/Ci7E6K4PXqsAF5TiDtbo8g</id>
    <link href="https://mp.weixin.qq.com/s/Ci7E6K4PXqsAF5TiDtbo8g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>遗传毒性杂质专栏——遗传毒性杂质风险评估简析（下）</title>
    <updated>2020-11-27T07:14:15+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-27:/s/_cdPWbXxXy1RzW2IdtBa5Q</id>
    <link href="https://mp.weixin.qq.com/s/_cdPWbXxXy1RzW2IdtBa5Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>Cell Research | 人源胰高血糖素样肽-2受体复合物三维结构成功解析</title>
    <updated>2020-11-27T07:14:15+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-27:/s/1dPBRkJCA5n_IAGJKmbn-g</id>
    <link href="https://mp.weixin.qq.com/s/1dPBRkJCA5n_IAGJKmbn-g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>第二代选择性核输出抑制剂ATG-016(Eltanexor)治疗骨髓增生异常综合征的疗法在中国大陆获I/II期临床试验批准</title>
    <updated>2020-11-27T07:14:15+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-27:/s/DCIO6Soc6iShC5MLCS4Y0g</id>
    <link href="https://mp.weixin.qq.com/s/DCIO6Soc6iShC5MLCS4Y0g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>药明直播间|医疗器械测试系列(六)：病理学家如何推动医疗器械研发加速</title>
    <updated>2020-11-27T07:14:15+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-27:/s/DIxWW9Ti_yA9u3NvJzI5lw</id>
    <link href="https://mp.weixin.qq.com/s/DIxWW9Ti_yA9u3NvJzI5lw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>